Published by
@ShahidNShah
@ShahidNShah
October 10 to October 12, 2023
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
2023 is booming with novel psychiatric R AND D and the promise of precision medicine for neuropsychiatric patients. Pipelines are gaining momentum, with notable approvals on the horizon, as unmet needs in PTSD, bipolar, anxiety, schizophrenia, depression, and ADHD become greater and greater. There is, therefore, a huge deal of novel and promising research to be discussed this October at the 6th Neuropsychiatric Drug Development Summit.
With discovery, preclinical, translational, and clinical scientists from the likes of Biogen, Otsuka, AbbVie, Genentech, Lundbeck, Delix Therapeutics, Atai, Gilgamesh, and Cerevel Therapeutics, don't miss the field's favorite conference, specifically dedicated to biopharma's most pressing challenges of de-risking the translational gap and advancing transformative neuropsychiatric candidates through the clinic.
Continue reading at neuropsychiatric-drug-development.com
October 10 to October 12, 2023
Metro Toronto Convention Centre, 255 Front Street West, Toronto, Ontario, M5V 2W6, Canada
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 26, 2024 at 6:14am